Profound Medical‘s (Toronto, Canada) thermal coagulation therapy system is an interesting new product that MassDevice has just reported from MassMEDIC 11th Annual Medtech Investors Conference. The MRI-compatible ultrasound applicator, yet to undergo clinical trials, is designed to deliver controlled thermal ablation to prostate cancer in an MRI via via a trans-urethral approach.
Features of the device:
Complete compatibility within an MRI suite Accurate location of the trans-urethral ultrasound applicator in the prostate Multiple 3D treatment planning options through proprietary software Precise heating control through unique array geometries and frequencies Whole or segmented treatments relative to disease progression and location Single or multiple treatments in the same session Real-time thermometry for active monitoring and surveillance Highest control around organs such as nerve bundles, rectum & urethra Treatment time estimates of 30 mins (6X faster than next best)
Product page: Profound Medical Treatment System…
More from MassDevice…
